Concise Prescribing Info Bahasa Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Contraindications Special Precautions Adverse Reactions Drug Interactions Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Indications/Uses

Prevention of urothelial toxicity due to Oxazaphosphorines.
UROMESAN should always be given in tumour therapy with Ifosfamide. Where Cyclophosphamide is being used for tumour therapy, UROMESAN should always be given with bolus doses (over 10 mg/kg) of the cytotoxic agent and in all patients at special risk.
The principle risk factors are: Previous pelvic radiotherapy, cystitis with previous Ifosfamide, Cyclophosphamide therapy or a history of disorders of the urinary tract.

Uromesan Indications/Uses

mesna

Manufacturer:

Sanbe